EYE 0.00% 24.0¢ nova eye medical limited

No problem. The sales figures in the half year and full year...

  1. 15,795 Posts.
    lightbulb Created with Sketch. 4074
    No problem. The sales figures in the half year and full year FY24 reports will obviously be the best source of new investors but it is definitely fantastic to see them engaging in events like this to hopefully get a bit more interest in advance of those reports. This has definitely always been a very tightly held stock. The CR investors changed that for a bit but they seem to have been all washed out and replaced by long termers.

    Still can't fathom how the share price is so low though. This is a company generating revenue with a very strong and loyal customer base. Recurring revenue, very high gross margins, countless patents, solid and experienced management team, a brand new best in class product, enormous R&D pipeline, high growth and large markets... the list goes on - everything screams a high quality company deserving of a premium valuation
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.000(0.00%)
Mkt cap ! $54.91M
Open High Low Value Volume
24.0¢ 24.5¢ 24.0¢ $110.1K 458.4K

Buyers (Bids)

No. Vol. Price($)
4 432506 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 169560 3
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.